Glenmark Pharmaceuticals announces Q2 results

Glenmark Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended September 30, 2009:

The results for the Quarter ended September 30, 2009

The Company has posted a net profit after tax of Rs 575.018 million for the quarter ended September 30, 2009 as compared to Rs 668.867 million for the quarter ended September 30, 2008. Total Income has decreased from Rs 2513.705 million for the quarter ended September 30, 2008 to Rs 2387.133 million for the quarter ended September 30, 2009.

The Consolidated results are as follows:

The consolidated results for the Quarter ended September 30, 2009

The Group has posted a net profit after tax of Rs 808.851 million for the quarter ended September 30, 2009 as compared to Rs 1173.601 million for the quarter ended September 30, 2008. Total Income has increased from Rs 6042.114 million for the quarter ended September 30, 2008 to Rs 6165.571 million for the quarter ended September 30, 2009.